The Cambridge-based biotech offered a first public peek of the earlier test results -- in 10 people ages 56 to 70, and 10 over 70 -- at a meeting of advisers to the Centers for Disease Control and Prevention.
↧
The Cambridge-based biotech offered a first public peek of the earlier test results -- in 10 people ages 56 to 70, and 10 over 70 -- at a meeting of advisers to the Centers for Disease Control and Prevention.